Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining

This study has been completed.
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
First received: June 1, 2007
Last updated: July 23, 2007
Last verified: July 2007
To evaluate corneal staining after contact lens instillation with two different multi purpose solutions.

Condition Intervention Phase
Corneal Staining
Drug: sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind

Further study details as provided by Innovative Medical:


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both

Inclusion Criteria:

  • Patients 18 yrs or older
  • Males or females
  • Any race or ethnic background
  • CL patients using (multipurpose solutions) MPS
  • Patients using Acuvue 2 lenses

Exclusion Criteria:

  • Corneal refractive surgery within 6 months of this study.
  • Contact lens use on day of examination.
  • Corneal ectasia.
  • Current use of Restasis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00483795

United States, Pennsylvania
Hazleton Eye Specialists
Hazleton, Pennsylvania, United States, 18202
Sponsors and Collaborators
Innovative Medical
Principal Investigator: Thomas Kislan, OD Hazleton Eye Specialists
  More Information

ClinicalTrials.gov Identifier: NCT00483795     History of Changes
Other Study ID Numbers: 5308 
Study First Received: June 1, 2007
Last Updated: July 23, 2007
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on May 30, 2016